Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk assessment of cancer patients based on HLA-I alleles, neobinders and expression of cytokines.

Computers in biology and medicine - 1 Dec 2023

Dhall Anjali, Patiyal Sumeet, Kaur Harpreet, Raghava Gajendra P S

Abstract excerpt

Advancements in cancer immunotherapy have shown significant outcomes in treating cancers. To design effective immunotherapy, it's important to understand immune response of a patient based on its genomic profile. However, analyses to do that requires proficiency in the bioinformatic methods. Swiftly growing sequencing technologies and statistical methods create a blockage for the scientists who want to find the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Biomarkers
Share to Carcinoma, Transitional Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytokines

Share to Lung Neoplasms

Share to Risk Assessment

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 37918263
DOI: 10.1016/j.compbiomed.2023.107594

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk assessment of cancer patients based on HLA-I alleles, neobinders and expression of cytokines.PMID 37918263Read ↗

Risk assessment of cancer patients based on HLA-I alleles, neobinders and expression of cytokinesSemantic proximity Read ↗

HLA ligandome tumor antigen discovery for personalized vaccine approachSemantic proximity Read ↗

Comprehensive analysis of prognosis markers with molecular features derived from pan-cancer whole-genome sequences.Semantic proximity Read ↗

The HLA Ligand Atlas - A resource of natural HLA ligands presented on benign tissuesSemantic proximity Read ↗

The HLA-I landscape confers prognosis and antitumor immunity in breast cancer.Semantic proximity Read ↗

HLA genotyping meets response to immune checkpoint inhibitors prediction: A story just started.Semantic proximity Read ↗

HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study.Semantic proximity Read ↗

Pan-Cancer HLA Gene-Mediated Tumor Immunogenicity and Immune EvasionSemantic proximity Read ↗

Benchmarking HLA genotyping and clarifying HLA impact on survival in tumor immunotherapy.Semantic proximity Read ↗

Identification of Mutated Peptides in Bladder Cancer From Exomic Sequencing Data Reveals Negative Correlation Between Mutation-Specific Immunoreactivity and Inflammation.Semantic proximity Read ↗

Computing Skin Cutaneous Melanoma Outcome from the HLA-alleles and Clinical CharacteristicsSemantic proximity Read ↗

Pharmaco-therapeutic challenges in cancer biology with focus on the immune- system related risk factors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.